MTOR and breast neoplasm: We propose that deficiency of the lysosomal endoproteinase Ctsl in mammary cancers results in a lysosomal storage phenotype, altered amino acid levels, and interference with mTOR signaling, causing the six-week delay observed for MMTV-Cre/Ctsl−/− breast tumors.